Correlation Between Terns Pharmaceuticals and Artelo Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Artelo Biosciences, you can compare the effects of market volatilities on Terns Pharmaceuticals and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Artelo Biosciences.

Diversification Opportunities for Terns Pharmaceuticals and Artelo Biosciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Terns and Artelo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Artelo Biosciences go up and down completely randomly.

Pair Corralation between Terns Pharmaceuticals and Artelo Biosciences

Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 1.01 times more return on investment than Artelo Biosciences. However, Terns Pharmaceuticals is 1.01 times more volatile than Artelo Biosciences. It trades about -0.02 of its potential returns per unit of risk. Artelo Biosciences is currently generating about -0.04 per unit of risk. If you would invest  723.00  in Terns Pharmaceuticals on September 2, 2024 and sell it today you would lose (99.00) from holding Terns Pharmaceuticals or give up 13.69% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Terns Pharmaceuticals  vs.  Artelo Biosciences

 Performance 
       Timeline  
Terns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Terns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Artelo Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Terns Pharmaceuticals and Artelo Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Terns Pharmaceuticals and Artelo Biosciences

The main advantage of trading using opposite Terns Pharmaceuticals and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.
The idea behind Terns Pharmaceuticals and Artelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance